Cargando…
LongShengZhi Capsule Attenuates Alzheimer-Like Pathology in APP/PS1 Double Transgenic Mice by Reducing Neuronal Oxidative Stress and Inflammation
Alzheimer’s disease (AD) is the most common form of dementia in the elderly. It may be caused by oxidative stress, inflammation, and cerebrovascular dysfunctions in the brain. LongShengZhi Capsule (LSZ), a traditional Chinese medicine, has been approved by the China Food and Drug Administration for...
Autores principales: | Yin, Zequn, Wang, Xuerui, Zheng, Shihong, Cao, Peichang, Chen, Yuanli, Yu, Maoyun, Liao, Chenzhong, Zhang, Zhongyuan, Han, Jihong, Duan, Yajun, Yang, Xiaoxiao, Zhang, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719723/ https://www.ncbi.nlm.nih.gov/pubmed/33328962 http://dx.doi.org/10.3389/fnagi.2020.582455 |
Ejemplares similares
-
Efficacy and safety of LongShengZhi capsule on functional recovery after acute ischemic stroke (LONGAN): Protocol and statistical analysis plan for a randomized, double-blind, placebo-controlled trial
por: Zhang, Dandan, et al.
Publicado: (2022) -
Longshengzhi Capsules Improve Ischemic Stroke Outcomes and Reperfusion Injury via the Promotion of Anti-Inflammatory and Neuroprotective Effects in MCAO/R Rats
por: Yang, Weinan, et al.
Publicado: (2020) -
Hainan zhi wu zhi /
Publicado: (1964) -
Procyanidin B2 Reduces Vascular Calcification through Inactivation of ERK1/2-RUNX2 Pathway
por: Liang, Yingquan, et al.
Publicado: (2021) -
Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)